Based on the research from the document provided, here is an analysis of the Research Impact Dimensions:

1. Domains of Research Impact
Excerpts:

The study focuses on the effectiveness of levonorgestrel-releasing intrauterine system (LNG-IUS) compared to oral progestogens in treating endometrial hyperplasia (EH), specifically complex hyperplasia (CH) and atypical complex hyperplasia (ACH). This research has implications across several domains:
Healthcare Domain: The research directly impacts treatment protocols for EH and cancer prevention in women, contributing to improved outcomes in gynecology.
Policy Domain: Findings could influence medical guidelines, especially regarding long-term management of EH patients, advising against discontinuing follow-up after initial regression.
Page Reference: Introduction, Methods, and Discussion sections, pages 1-3​(2).
2. Duration of Research Impact
Excerpts:

Short-term Impact: This research immediately influences clinical practice by advocating long-term follow-up for women treated for EH to prevent relapse.

Long-term Impact: Over time, the study contributes to foundational knowledge about the progression of EH to cancer, informing future studies on the risk of relapse and treatment efficacy.

Page Reference: Results and Discussion, page 4​(Knowledge - Potential R…).

3. Stakeholder of Research Impact
Excerpts:

Direct Stakeholders: Gynecologists and healthcare providers are the immediate beneficiaries as they apply findings to clinical settings for treating EH.

Indirect Stakeholders: Patients benefit from improved care protocols that potentially reduce cancer risk.

Page Reference: Methods and Discussion, pages 2-4​(Knowledge - Potential R…)​(2).

4. Depth and Breadth of Impact
Excerpts:

Depth of Impact: The study has a deep impact within the field of gynecology by improving treatment protocols for EH. It advances understanding of hormonal therapies for hyperplasia, particularly with LNG-IUS.

Breadth of Impact: The findings could have broader implications in healthcare and policy, influencing guidelines on women's health, cancer prevention, and long-term patient care.

Page Reference: Discussion, page 5​(2)​(Knowledge - Potential R…).

5. Scalability and Transferability
Excerpts:

Scalability: The research findings could be scaled up to national and international healthcare systems, improving protocols for treating EH worldwide.

Transferability: The approach of using hormonal therapies could be transferred to managing other gynecological conditions that involve hormone-sensitive tissue.

Page Reference: Discussion, page 5​(Knowledge - Potential R…).

6. Innovation and Disruption Potential
Excerpts:

Innovation: The study innovates by comparing LNG-IUS to oral progestogens, providing new insights into long-term management of EH.

Disruption: The findings could disrupt current medical practices by changing how clinicians manage the risk of relapse and long-term follow-up in EH patients.

Page Reference: Introduction and Methods, pages 2-3​(2)​(Knowledge - Potential R…).

These dimensions reflect the comprehensive and far-reaching impact of the research findings on clinical practice, patient care, and healthcare policy.




Continuing with the remaining research impact dimensions based on the study you provided:

7. Sustainability and Ethical Considerations
Excerpts:

Sustainability: The study emphasizes a sustainable approach to treating endometrial hyperplasia (EH) by promoting non-surgical methods such as LNG-IUS and oral progestogens instead of invasive hysterectomy. This promotes a less resource-intensive and more patient-centered approach, reducing the need for surgical interventions and related healthcare resources.

Ethical Considerations: The research follows ethical considerations by focusing on fertility-preserving treatments for women who wish to avoid hysterectomy. It also highlights the need for informed patient consent, especially in treatment decisions between hormonal therapy and surgery.

Page Reference: Methods and Discussion, pages 3-5​(2)​(Knowledge - Potential R…).

8. Implementation and Usability
Excerpts:

The study is highly implementable and usable for clinical practitioners. It provides clear data on the effectiveness of LNG-IUS versus oral progestogens, which helps healthcare providers decide on suitable treatment options based on relapse risk and patient preferences. The usability of these treatment protocols is significant in routine gynecological care for preventing the progression of EH to cancer.

Page Reference: Results and Recommendations, pages 4-5​(Knowledge - Potential R…).

9. Cross-disciplinary and Global Relevance
Excerpts:

Cross-disciplinary Relevance: The research findings have implications beyond gynecology, impacting endocrinology (hormonal regulation), oncology (cancer prevention), and public health (improved patient outcomes through non-surgical management).

Global Relevance: Endometrial hyperplasia is a common condition across different populations worldwide, making these findings relevant globally. The comparative effectiveness data for LNG-IUS and oral progestogens can be applied in different healthcare settings, potentially standardizing EH management globally.

Page Reference: Introduction and Discussion, pages 2-5​(Knowledge - Potential R…).

10. Resilience and Adaptability
Excerpts:

Resilience: The study's emphasis on long-term follow-up strategies illustrates the resilience aspect, showing that patients and healthcare systems can adapt to continuous changes in treatment response and ensure long-term health outcomes.

Adaptability: By presenting flexible treatment options (LNG-IUS versus oral progestogens), the study supports adaptability in clinical practice based on individual patient needs, health conditions, and preferences. It also informs how healthcare practitioners might alter treatment plans if a patient relapses after initial regression.

Page Reference: Results and Conclusions, pages 4-5​(Knowledge - Potential R…).

Summary
The research on the relapse of endometrial hyperplasia provides a multi-dimensional impact across different domains:

Domains of Research Impact: Influences healthcare, policy, and treatment protocols.
Duration of Impact: Both short-term effects in clinical practice and long-term foundational impacts on EH treatment.
Stakeholders of Impact: Direct impact on healthcare providers and indirect benefits for patients.
Depth and Breadth: Deep impact within gynecology and broader influence on women's health policy.
Scalability and Transferability: Treatment protocols can be scaled and transferred to broader healthcare systems.
Innovation and Disruption: Innovates by emphasizing non-surgical treatments; disrupts by challenging existing follow-up guidelines.
Sustainability and Ethical Considerations: Promotes sustainable, fertility-preserving treatments with ethical emphasis on patient choice.
Implementation and Usability: Easily usable in clinical settings to improve patient outcomes.
Cross-disciplinary and Global Relevance: Relevance in multiple fields and across global healthcare systems.
Resilience and Adaptability: Encourages adaptable and resilient treatment strategies for EH.
These dimensions collectively highlight the broad and deep implications of this research, making significant strides in patient-centered care, influencing clinical guidelines, and promoting sustainable healthcare practices.